View Post

Adenovirus Vectors As HIV-1 Vaccines: Where are We? What Next? AIDS, 29(4): 395-400.

In by AHFNovember 1, 2014

View Post

Engineering the Human Thymic Microenvironment to Support Thymopoiesis In Vivo. Stem Cells, 32: 2386-2396.

In by AHFSeptember 15, 2014

View Post

Ineffectual Targeting of HIV-1 Nef by Cytotoxic T Lymphocytes in Acute Infection Results in No Functional Impairment or Viremia Reduction. Journal of Virology, 88(14): 7881-7892.

In by AHFJuly 15, 2014

View Post

Home-Based HIV Testing for Men Who Have Sex with Men in China: A Novel Community-Based Partnership to Complement Government Programs. PLOS ONE, 9(7): 1-7.

In by AHFJuly 1, 2014

View Post

Modeling Scenarios for the End of AIDS. Clinical Infectious Diseases, 59(Suppl. 1): S16-S20.

In by AHFJuly 1, 2014

View Post

Linkage to Care Following Community-Based Mobile HIV Testing Compared with Clinic-Based Testing in Umlazi Township, Durban, South Africa. HIV Medicine, 15: 367-372.

In by AHFJuly 1, 2014

View Post

HIV-1 Quasispecies Delineation by Tag Linkage Deep Sequencing. PLOS ONE, 9(50): 1-10.

In by AHFMay 15, 2014

View Post

Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial. PLOS ONE, 9(5): 1-10.

In by AHFMay 15, 2014

View Post

Differential Blood and Mucosal Immune Responses Against an HIV-1 Vaccine Administered Via Inguinal or Deltoid Injection. PLOS ONE, 9(2): 1-11.

In by AHFFebruary 15, 2014

View Post

Predictors of Serological Failure after Treatment in HIV-Infected Patients with Early Syphilis in the Emerging Era of Universal Antiretroviral Therapy Use. BMC Infectious Diseases, 13: 1-6.

In by AHFDecember 1, 2013